Skip to main content
Search
Main content
Cereb Circ Cogn Behav
Published

A multi-disciplinary commentary on preclinical research to investigate vascular contributions to dementia.

Authors

Sarmi Sri, Adam Greenstein, Alessandra Granata, Alex Collcutt, Angela C C Jochems, Barry W McColl, Blanca Díaz Castro, Caleb Webber, Carmen Arteaga Reyes, Catherine Hall, Catherine B Lawrence, Cheryl Hawkes, Chrysia-Maria Pegasiou-Davies, Claire Gibson, Colin L Crawford, Colin Smith, Denis Vivien, Fiona H McLean, Frances Wiseman, Gaia Brezzo, Giovanna Lalli, Harry A T Pritchard, Hugh S Markus, Isabel Bravo-Ferrer, Jade Taylor, James Leiper, Jason Berwick, Jian Gan, John Gallacher, Jonathan Moss, Jozien Goense, Letitia McMullan, Lorraine Work, Lowri Evans, Michael S Stringer, Mlj Ashford, Mohamed Abulfadl, Nina Conlon, Paresh Malhotra, Philip Bath, Rebecca Canter, Rosalind Brown, Selvi Ince, Silvia Anderle, Simon Young, Sophie Quick, Stefan Szymkowiak, Steve Hill, Stuart Allan, Tao Wang, Terry Quinn, Tessa Procter, Tracy D Farr, Xiangjun Zhao, Zhiyuan Yang, Atticus H Hainsworth, Joanna M Wardlaw

Abstract

Although dementia research has been dominated by Alzheimer's disease (AD), most dementia in older people is now recognised to be due to mixed pathologies, usually combining vascular and AD brain pathology. Vascular cognitive impairment (VCI), which encompasses vascular dementia (VaD) is the second most common type of dementia. Models of VCI have been delayed by limited understanding of the underlying aetiology and pathogenesis. This review by a multidisciplinary, diverse (in terms of sex, geography and career stage), cross-institute team provides a perspective on limitations to current VCI models and recommendations for improving translation and reproducibility. We discuss reproducibility, clinical features of VCI and corresponding assessments in models, human pathology, bioinformatics approaches, and data sharing. We offer recommendations for future research, particularly focusing on small vessel disease as a main underpinning disorder.

PMID:37941765 | DOI:10.1016/j.cccb.2023.100189

UK DRI Authors

Caleb Webber

Prof Caleb Webber

Director of Data Science & Group Leader

Combining state-of-the-art stem cell models with bioinformatics techniques to boost our understanding of the biological mechanisms underlying Parkinson’s disease

Prof Caleb Webber
Colin Smith Profile

Prof Colin Smith

Chair of Neuropathology; Director of Centre for Clinical Brain Sciences

Prof Colin Smith
Denis Vivien

Prof Denis Vivien

Professor of Cell Biology, University of Caen Normandy

Prof Denis Vivien
Frances Wiseman profile

Dr Frances Wiseman

Group Leader and Programme Leader for Animal Models

Investigating dementia in people living with Down syndrome

Dr Frances Wiseman
Jian Gan

Dr Jian Gan

Group Leader

Understanding why and how neurons and brain circuits become dysfunctional in vivo

Dr Jian Gan
John Gallacher

Prof John Gallacher

Professor of Cognitive Health; Director, Dementias Platform UK; Director, BrainWaves Study of Adolescent Wellbeing and Mental Health, University of Oxford

Prof John Gallacher
Paresh Malhotra

Dr Paresh Malhotra

UK DRI Associate Member

Reader in Cognitive & Behavioural Neurology, Imperial College London

Dr Paresh Malhotra
Terry Quinn

Prof Terry Quinn

Professor in Cardiovascular Ageing, University of Glasgow

Prof Terry Quinn